6A3A Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Autolus Therapeutics PLC

Watchlist Manager

Watchlist

Price: 1.78 EUR

Market Cap: €195.4m

A	Autolus Therapeutics PLC SWB:6A3A	UK
F	Function International PCL SET:FTI	TH
R	Rio Tinto Ltd XMUN:CRA1	AU

Profitability Summary

Autolus Therapeutics PLC's profitability score is 14/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

18%

Negative 3Y Average Gross Margin

-39%

Negative Operating Margin

-205%

Negative 3Y Average Operating Margin

-2,044%

Operating Margin is Increasing

-3,082% > -205%

Negative Net Margin

-239%

Negative 3Y Average Net Margin

-2,279%

Net Margin is Increasing

-2,860% > -239%

Negative Free Cash Flow Margin

-205%

Negative 3Y Average Free Cash Flow Margin

-2,081%

Free Cash Flow Margin is Increasing

-2,630% > -205%

Negative ROE

-133%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-121%

ROIC is Increasing

-123% > -88%

View All

Hide

Collapse

14 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

18%

Negative 3Y Average Gross Margin

-39%

Negative Operating Margin

-205%

Negative 3Y Average Operating Margin

-2,044%

Operating Margin is Increasing

-3,082% > -205%

Negative Net Margin

-239%